title: Contributions of other brain pathologies in dementia with lewy bodies.
abstract: The clinical picture with its pathological correlate was analysed in 16 patients fulfilling consensus criteria for dementia with Lewy bodies (DLB). The cases were part of a larger cohort (n = 200) of patients within a prospective longitudinal study of dementing disorders. Six cases exhibited not only Lewy bodies (LBs) but also other brain pathologies such as Alzheimer changes, multiple infarcts or complete and incomplete white matter infarcts. Degeneration of the nucleus basalis of Meynert and substantia nigra was also seen. The 10 cases without LBs all had Alzheimer changes. In 7 cases, these changes were combined with mainly incomplete frontal white matter infarcts. However, the degeneration of brain stem nuclei was less pronounced in these cases. Symptoms such as fluctuations in cognition, falls and episodic confusion appeared in association with arterial hypotension, which developed during the course of dementia in almost all the 16 cases. The majority of the cases were treated with neuroleptics and other potentially hypotensive medication. This study shows that multiple and different pathological features may contribute to a clinical symptom constellation as in DLB. The case study approach reveals the complexity of the clinico-pathological relationships in dementia that might otherwise be lost in the analysis of larger group data.
authors.affiliation: Department of Psychogeriatrics and Pathology, University Hospital, Lund, Sweden. elisabet.londos@psykiatr.lu.se
authors.forename: E
authors.initials: E
authors.lastname: Londos
authors.forename: U
authors.initials: U
authors.lastname: Passant
authors.forename: J
authors.initials: J
authors.lastname: Risberg
authors.forename: L
authors.initials: L
authors.lastname: Gustafson
authors.forename: A
authors.initials: A
authors.lastname: Brun
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000000981:diagnostic imaging / Q000473:pathology; D001769:Blood; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging / Q000473:pathology; D002544:Cerebral Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D002560:Cerebrovascular Circulation; D005260:Female; D006212:Hallucinations / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D020961:Lewy Body Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D014980:Xenon Radioisotopes
chemical_list: D014150:Antipsychotic Agents; D014980:Xenon Radioisotopes